Recommendations in the management of epithelial appendiceal neoplasms and peritoneal dissemination from mucinous tumours (pseudomyxoma peritonei)

[1]  M. Ducreux,et al.  Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases. , 2014, European journal of cancer.

[2]  G. Nash,et al.  Peritoneal debulking/intraperitoneal chemotherapy—non‐sarcoma , 2014, Journal of surgical oncology.

[3]  B. Moran,et al.  Complete Cytoreduction for Pseudomyxoma Peritonei Is Optimal but Maximal Tumor Debulking May Be Beneficial in Patients in Whom Complete Tumor Removal Cannot Be Achieved , 2013, Diseases of the colon and rectum.

[4]  R. Chetty,et al.  Mucinous tumours of appendix and ovary: an overview and evaluation of current practice , 2013, Journal of Clinical Pathology.

[5]  E. Levine,et al.  Current status and future directions in appendiceal cancer with peritoneal dissemination. , 2012, Surgical oncology clinics of North America.

[6]  E. Cotte,et al.  Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: Postoperative and long‐term results , 2012, Journal of surgical oncology.

[7]  T. Chua,et al.  Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. Wolff,et al.  Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  T. Chua,et al.  Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome , 2012, International Journal of Colorectal Disease.

[10]  Ki Bum Park,et al.  Single-incision Laparoscopic Surgery for Appendiceal Mucoceles: Safety and Feasibility in a Series of 16 Consecutive Cases , 2011, Journal of the Korean Society of Coloproctology.

[11]  B. Moran,et al.  Operative Findings, Early Complications, and Long-Term Survival in 456 Patients With Pseudomyxoma Peritonei Syndrome of Appendiceal Origin , 2011, Diseases of the colon and rectum.

[12]  P. Sugarbaker,et al.  Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin , 2010, Journal of surgical oncology.

[13]  R. Wolff,et al.  Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin , 2010, Cancer.

[14]  N. Sirtaine,et al.  How Should we Treat Mucinous Appendiceal Neoplasm ? By Laparoscopy or Laparotomy ?: A Case Report , 2010, Acta chirurgica Belgica.

[15]  F. Bosman,et al.  WHO Classification of Tumours of the Digestive System , 2010 .

[16]  D. Elias,et al.  The Second Procedure Combining Complete Cytoreductive Surgery and Intraperitoneal Chemotherapy for Isolated Peritoneal Recurrence: Postoperative Course and Long-Term Outcome , 2009, Annals of Surgical Oncology.

[17]  T. Chua,et al.  Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure?: A Systematic Review of Morbidity and Mortality , 2009, Annals of surgery.

[18]  P. Sugarbaker.  Epithelial Appendiceal Neoplasms , 2009, Cancer journal.

[19]  D. Elias,et al.  Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  R. Yantiss,et al.  Prognostic Significance of Localized Extra-appendiceal Mucin Deposition in Appendiceal Mucinous Neoplasms , 2009, The American journal of surgical pathology.

[21]  W. Kang,et al.  Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4) , 2008, World journal of surgical oncology.

[22]  B. Moran,et al.  Consensus statement on the loco‐regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei) , 2008, Journal of surgical oncology.

[23]  P. Sugarbaker,et al.  Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms , 2008, Journal of surgical oncology.

[24]  D. Marcello,et al.  The intraoperative staging systems in the management of peritoneal surface malignancy , 2008, Journal of surgical oncology.

[25]  G. Witham,et al.  A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei , 2008, British Journal of Cancer.

[26]  M. V. van Velthuysen,et al.  Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[27]  P. Sugarbaker,et al.  Critical Analysis of Treatment Failure After Complete Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Dissemination From Appendiceal Mucinous Neoplasms , 2007, Annals of Surgical Oncology.

[28]  P. Sugarbaker.  Peritoneum as the first‐line of defense in carcinomatosis , 2007, Journal of surgical oncology.

[29]  V. Verwaal.  Detection and treatment of recurrent disease after cytoreduction and HIPEC. , 2007, Cancer treatment and research.

[30]  E. Levine,et al.  Survival and Health Outcomes After Cytoreductive Surgery With Intraperitoneal Hyperthermic Chemotherapy for Disseminated Peritoneal Cancer of Appendiceal Origin , 2007, Annals of Surgical Oncology.

[31]  P. Sugarbaker,et al.  A Systematic Review on the Efficacy of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei , 2007, Annals of Surgical Oncology.

[32]  E. Murphy,et al.  Management of an unexpected appendiceal neoplasm , 2006, The British journal of surgery.

[33]  K. Geisinger,et al.  Pseudomyxoma Peritonei of Appendiceal Origin: A Clinicopathologic Analysis of 101 Patients Uniformly Treated at a Single Institution, With Literature Review , 2006, The American journal of surgical pathology.

[34]  P. Sugarbaker,et al.  Update on the surgical approach to mucocele of the appendix. , 2006, Journal of the American College of Surgeons.

[35]  K. Geisinger,et al.  Appendiceal Neoplasms With Peritoneal Dissemination: Outcomes After Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy , 2006, Annals of Surgical Oncology.

[36]  J. Esquivel,et al.  Prospective Morbidity and Mortality Assessment of Cytoreductive Surgery Plus Perioperative Intraperitoneal Chemotherapy To Treat Peritoneal Dissemination of Appendiceal Mucinous Malignancy , 2006, Annals of Surgical Oncology.

[37]  P. Sugarbaker.  New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? , 2006, The Lancet. Oncology.

[38]  Werth.  Klinische und anatomische Untersuchungen zur Lehre von den Bauchgeschwülsten und der Laparatomie , 1884, Archiv für Gynäkologie.

[39]  E. Brun,et al.  Lymph Node Metastasis in Epithelial Malignancies of the Appendix With Peritoneal Dissemination Does Not Reduce Survival in Patients Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy , 2005, Annals of surgical oncology.

[40]  D. Chang,et al.  Utility of CEA and CA 19‐9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix , 2004, Journal of surgical oncology.

[41]  P. Román-Zepeda,et al.  [Appendiceal tumors. Clinicopathologic review of 5,307 appendectomies]. , 2004, Cirugia y cirujanos.

[42]  P. Sugarbaker,et al.  Incomplete Cytoreduction in 174 Patients With Peritoneal Carcinomatosis From Appendiceal Malignancy , 2004, Annals of surgery.

[43]  B. Varisco,et al.  Adenocarcinoid of the Appendix: Is Right Hemicolectomy Necessary? A Meta-analysis of Retrospective Chart Reviews , 2004, The American surgeon.

[44]  S. Andreola,et al.  Peritonectomy and Intraperitoneal Hyperthermic Perfusion (IPHP): A Strategy That Has Confirmed its Efficacy in Patients with Pseudomyxoma Peritonei , 2004, Annals of Surgical Oncology.

[45]  P. Sugarbaker,et al.  Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding , 2004, The British journal of surgery.

[46]  P. Sugarbaker,et al.  Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread , 2003, Cancer and Metastasis Reviews.

[47]  José-Luis Martínez-Ordáz,et al.  Tumores apendiculares. Revisión clínico-patológica de 5,307 apendicectomías , 2004 .

[48]  P. Morel,et al.  Appendix tumors in the era of laparoscopic appendectomy , 2004, Surgical Endoscopy And Other Interventional Techniques.

[49]  R. Yantiss,et al.  Appendiceal Mucinous Neoplasms: A Clinicopathologic Analysis of 107 Cases , 2003, The American journal of surgical pathology.

[50]  B. Moran,et al.  The etiology, clinical presentation, and management of pseudomyxoma peritonei. , 2003, Surgical oncology clinics of North America.

[51]  D. Larson,et al.  Surgical treatment of appendiceal mucocele. , 2003, Archives of surgery.

[52]  P. Sugarbaker,et al.  Third look surgery and beyond for appendiceal malignancy with peritoneal dissemination , 2003, Journal of surgical oncology.

[53]  F. Gilly,et al.  Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  A. Hart,et al.  Heat penetration in locally applied hyperthermia in the abdomen during intra-operative hyperthermic intraperitoneal chemotherapy. , 2003, Anticancer research.

[55]  P. Sugarbaker.  Peritonectomy Procedures , 1995, Surgical oncology clinics of North America.

[56]  R. Harshen,et al.  Pseudomyxoma peritonei. , 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).

[57]  P. Sugarbaker.  Cytoreduction including total gastrectomy for pseudomyxoma peritonei , 2002 .

[58]  P. Sugarbaker.  Cytoreduction including total gastrectomy for pseudomyxoma peritonei. , 2002, The British journal of surgery.

[59]  J. Esquivel,et al.  Second-Look Surgery in Patients With Peritoneal Dissemination From Appendiceal Malignancy: Analysis of Prognostic Factors in 98 Patients , 2001, Annals of surgery.

[60]  P. Sugarbaker.  Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[61]  P. Sugarbaker,et al.  Clinical presentation of the pseudomyxoma peritonei syndrome , 2000, The British journal of surgery.

[62]  A. Prescher,et al.  Appendix and cecum. Embryology, anatomy, and surgical applications. , 2000, The Surgical clinics of North America.

[63]  P. Sugarbaker,et al.  Results of Treatment of 385 Patients With Peritoneal Surface Spread of Appendiceal Malignancy , 1999, Annals of Surgical Oncology.

[64]  S. Connor,et al.  Appendiceal tumors , 1998, Diseases of the colon and rectum.

[65]  B. Shmookler,et al.  Appendiceal mucocele. Contraindication to laparoscopic appendectomy. , 1998, Surgical endoscopy.

[66]  P. Sugarbaker,et al.  Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. , 1996, Cancer treatment and research.

[67]  F. Shamsa,et al.  Clinical determinants of treatment failure in patients with pseudomyxoma peritonei. , 1996, Cancer treatment and research.

[68]  P. Sugarbaker,et al.  Krukenberg syndrome as a natural manifestation of tumor cell entrapment. , 1996, Cancer treatment and research.

[69]  P. H. Sugarbaker,et al.  Pseudomyxoma peritonei syndrome. , 1996, Advances in surgery.

[70]  R. Kurman,et al.  Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". , 1995, The American journal of surgical pathology.

[71]  G. Santos,et al.  Neoplastic lesions of the appendix , 1995, The British journal of surgery.

[72]  B. Debaene,et al.  Treatment of peritoneal carcinomatosis by intraperitoneal chemo-hyperthermia: reliable and unreliable concepts. , 1994, Hepato-gastroenterology.

[73]  P. Sugarbaker.  Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. , 1994, Annals of surgery.

[74]  J. Donohue,et al.  Pseudomyxoma Peritonei Long‐Term Patient Survival with an Aggressive Regional Approach , 1994, Annals of surgery.

[75]  A. Huvos,et al.  Pseudomyxoma peritonei of appendiceal origin. The memorial sloan‐kettering cancer center experience , 1992, Cancer.

[76]  C. Gilks,et al.  Mucinous Tumors of the Appendix Associated With Mucinous Tumors of the Ovary and Pseudomyxoma Peritonei: A Clinicopathological Analysis of 22 Cases Supporting an Origin in the Appendix , 1991, The American journal of surgical pathology.

[77]  Y. Osaki,et al.  Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug. , 1984, Cancer research.

[78]  J. Spratt,et al.  Clinical delivery system for intraperitoneal hyperthermic chemotherapy. , 1980, Cancer research.

[79]  D. Collins.  71,000 HUMAN APPENDIX SPECIMENS. A FINAL REPORT, SUMMARIZING FORTY YEARS' STUDY. , 1963, American journal of proctology.

[80]  K. Hesketh.  The management of primary adenocarcinoma of the vermiform appendix , 1963, Gut.